Q32 Bio (QTTB) announced the appointment of Lee Kalowski as President and CFO. Kalowski brings over 20 years of biopharmaceutical experience with a focus on strategy, raising capital, and financial operations. Prior to joining Q32 Bio, Kalowski served as President and CFO of Bicycle Therapeutics (BCYC) where he led strategic finance and operations and oversaw the company’s transition to a public clinical-stage biotech company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB:
